Jayakumar Rajadas

257 posts

Jayakumar Rajadas banner
Jayakumar Rajadas

Jayakumar Rajadas

@JayRajadas

Katılım Şubat 2016
392 Takip Edilen153 Takipçiler
Jayakumar Rajadas retweetledi
BookNote
BookNote@BookNoteApp·
7 books to fall in love with biology: 1) The Lives of a Cell by Lewis Thomas
BookNote tweet media
English
16
249
1.4K
90.7K
Jayakumar Rajadas
Jayakumar Rajadas@JayRajadas·
Agreed
Aakash Gupta@aakashgupta

The proteins that reverse aging are the same ones that accelerate cancer. UCSF screened 200 transcription factors and found 4 that push old cells back to a youthful state. Two of them, EZH2 and E2F3, are classified oncogenes. EZH2 is overexpressed in melanoma, ovarian, breast, endometrial, bladder, renal, lung, and liver cancer. It silences tumor suppressor genes including p16. E2F3 shows overexpression in 67% of prostate cancers and independently predicts worse survival. The mechanism that makes old cells divide again is the same mechanism that makes cancer cells divide uncontrollably. This is the central tradeoff in longevity science that nobody wants to talk about. Senescence evolved as tumor suppression. Cells that stop dividing can’t become cancer. Reverse that brake, and you’re rolling dice on which cells wake up first. The mouse results are real. In 20-month-old mice (equivalent to 65 human years), EZH2 reversed liver fibrosis, cut liver fat in half, and improved glucose tolerance. But the same protein that regenerated liver tissue also drives prostate cancer proliferation and acts as a coactivator for androgen receptor signaling. The researchers acknowledge they’re looking for “safer rejuvenation therapies.” That phrasing tells you the current approach has a safety problem. Aging research keeps running into this wall: the pathways that decline with age often declined because evolution selected for cancer suppression over longevity. You don’t reverse aging without confronting that tradeoff. The real breakthrough will be tissue-specific or temporally controlled activation. Until then, every “reverse aging” headline needs an asterisk.

English
0
0
0
50
Jayakumar Rajadas retweetledi
Aakash Gupta
Aakash Gupta@aakashgupta·
The proteins that reverse aging are the same ones that accelerate cancer. UCSF screened 200 transcription factors and found 4 that push old cells back to a youthful state. Two of them, EZH2 and E2F3, are classified oncogenes. EZH2 is overexpressed in melanoma, ovarian, breast, endometrial, bladder, renal, lung, and liver cancer. It silences tumor suppressor genes including p16. E2F3 shows overexpression in 67% of prostate cancers and independently predicts worse survival. The mechanism that makes old cells divide again is the same mechanism that makes cancer cells divide uncontrollably. This is the central tradeoff in longevity science that nobody wants to talk about. Senescence evolved as tumor suppression. Cells that stop dividing can’t become cancer. Reverse that brake, and you’re rolling dice on which cells wake up first. The mouse results are real. In 20-month-old mice (equivalent to 65 human years), EZH2 reversed liver fibrosis, cut liver fat in half, and improved glucose tolerance. But the same protein that regenerated liver tissue also drives prostate cancer proliferation and acts as a coactivator for androgen receptor signaling. The researchers acknowledge they’re looking for “safer rejuvenation therapies.” That phrasing tells you the current approach has a safety problem. Aging research keeps running into this wall: the pathways that decline with age often declined because evolution selected for cancer suppression over longevity. You don’t reverse aging without confronting that tradeoff. The real breakthrough will be tissue-specific or temporally controlled activation. Until then, every “reverse aging” headline needs an asterisk.
SciTech Era@SciTechera

Interesting CELLULAR AGING BREAKTHROUGH Scientists may have found a molecular blueprint to revive old cells. A new UCSF study identified four key transcription factors, E2F3, EZH2, STAT3, and ZFX, that can push aged cells back into a youthful state. By reactivating this gene control network, old human cells regained higher energy levels, increased cell division, and younger gene expression patterns. In aged mice, activating one of these factors reduced liver fat and scarring and improved glucose metabolism, making old tissue function more like young tissue. This discovery suggests aging isn’t just damage, it’s a loss of coordinated gene regulation that may be partially reversible. Instead of replacing cells or turning them into stem cells, this approach hints at resetting cells from within, opening a new path toward therapies focused on extending healthspan, not just lifespan.

English
73
175
1.2K
121.7K
Jayakumar Rajadas retweetledi
CardiovascularCorner
CardiovascularCorner@TrackYourHeart·
Visualization of atherosclerotic plaque formation leading to rupture, clotting cascade & platelet aggregation, resulting in total thrombus occlusion of an artery.
English
5
151
643
56.5K
Jayakumar Rajadas retweetledi
Stanford CVI
Stanford CVI@StanfordCVI·
Congratulations to @Joseph_C_Wu Director of the Stanford CVI, on being named President of the American Association of University Cardiologists (#AUC). Dr. Wu’s leadership and groundbreaking work continue to shape the field of cardiovascular medicine. @StanfordMed @Stanford
Stanford CVI tweet media
English
1
4
28
1.9K
Jayakumar Rajadas retweetledi
Satyendra Dhar, MD SFHM
Satyendra Dhar, MD SFHM@DharSaty·
Glucagon-like peptide 1 receptor agonists (GLP-1RAs): 👉GLP-1 is a peptide hormone released from the distal ileum & colon after oral nutrient intake. 👉GLP-1RA reduces glucose by increasing glucose-dependent insulin secretion from beta cells in the pancreas, by decreasing glucagon secretion, as well as by delaying gastric emptying, which leads to satiety. 👉Beneficial effects on important determinants of CV risk, including weight loss, blood pressure, & triglyceride reduction as well as anti-inflammatory effects. dharsaty.com
Satyendra Dhar, MD SFHM tweet media
English
4
69
227
9K
Jayakumar Rajadas retweetledi
Eric Topol
Eric Topol@EricTopol·
Discovery of a maladaptive heart-brain-immune system loop after a heart attack, and the ability to modulate it cell.com/cell/fulltext/…
Eric Topol tweet media
English
2
35
153
22.4K
Jayakumar Rajadas retweetledi
Satyendra Dhar, MD SFHM
Satyendra Dhar, MD SFHM@DharSaty·
SGLT2 Inhibitors: 👉SGLT2 is a sodium-glucose cotransporter in the proximal tubule of the nephron that is responsible for approximately 90% of urinary glucose reabsorption. 👉Inhibition results in glucose lowering through induction of glucosuria. 👉Cause diuretic and natriuretic effects, promote weight loss, and lower systolic blood pressure. 👉Reductions in preload and afterload through diuresis, alterations in myocardial metabolism, and prevention of myocardial fibrosis. dharsaty.com
Satyendra Dhar, MD SFHM tweet media
English
1
120
411
16.1K